Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Bamias A, Moulopoulos LA, Koutras A, Aravantinos G, Fountzilas G, Pectasides D, Kastritis E, Gika D, Skarlos D, Linardou H, Kalofonos HP, Dimopoulos MA. Bamias A, et al. Among authors: moulopoulos la. Cancer. 2006 Jan 15;106(2):297-303. doi: 10.1002/cncr.21604. Cancer. 2006. PMID: 16342065 Free article. Clinical Trial.
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.
Papadimitriou CA, Fountzilas G, Aravantinos G, Kalofonos C, Moulopoulos LA, Briassoulis E, Gika D, Dimopoulos MA; Hellenic Cooperative Oncology Group Study. Papadimitriou CA, et al. Among authors: moulopoulos la. Gynecol Oncol. 2004 Jan;92(1):152-9. doi: 10.1016/j.ygyno.2003.09.021. Gynecol Oncol. 2004. PMID: 14751151 Clinical Trial.
Non-Hodgkin's lymphoma of the renal pelvis.
Bozas G, Tassidou A, Moulopoulos LA, Constandinidis C, Bamias A, Dimopoulos MA. Bozas G, et al. Among authors: moulopoulos la. Clin Lymphoma Myeloma. 2006 Mar;6(5):404-6. doi: 10.3816/CLM.2006.n.018. Clin Lymphoma Myeloma. 2006. PMID: 16640818
Advances in imaging and the management of myeloma bone disease.
Terpos E, Moulopoulos LA, Dimopoulos MA. Terpos E, et al. Among authors: moulopoulos la. J Clin Oncol. 2011 May 10;29(14):1907-15. doi: 10.1200/JCO.2010.32.5449. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483016 Review.
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
Moulopoulos LA, Dimopoulos MA, Kastritis E, Christoulas D, Gkotzamanidou M, Roussou M, Koureas A, Migkou M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Gika D, Koutoulidis V, Terpos E. Moulopoulos LA, et al. Am J Hematol. 2012 Sep;87(9):861-4. doi: 10.1002/ajh.23258. Epub 2012 May 28. Am J Hematol. 2012. PMID: 22641455 Free article.
Sclerostin: a possible target for the management of cancer-induced bone disease.
Gkotzamanidou M, Dimopoulos MA, Kastritis E, Christoulas D, Moulopoulos LA, Terpos E. Gkotzamanidou M, et al. Among authors: moulopoulos la. Expert Opin Ther Targets. 2012 Aug;16(8):761-9. doi: 10.1517/14728222.2012.697154. Epub 2012 Jul 5. Expert Opin Ther Targets. 2012. PMID: 22762409 Review.
119 results